Is Tenable Stock a Buy, Sell or Hold?
Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…
Sell
7
RVPH Quote, Financials, Valuation and Earnings
Last price:
$1.04
Seasonality move
:
-10.09%
Day range:
$1.01 - $1.16
52-week range:
$0.60 - $4.28
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.2M
Avg. volume:
1.1M
1-year change:
-62.32%
Market cap:
$34.8M
Revenue:
--
EPS (TTM):
-$1.09
Earnings Data
Next earnings date for RVPH
Apr 15
2025
Most recent earnings per share
-$0.25
Missed by --
(Nov 14/2024)
Consensus Estimate
-$0.25
(Nov 14/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RVPH Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 04/15/2025 | Q1 | -- | -- | -- | -$0.23 | -- |
| 12/31/2024 | Q4 | -- | -- | -- | -$0.22 | -- |
| 11/14/2024 | Q3 | -- | -- | -$0.25 | -$0.25 | -- |
| 08/14/2024 | Q2 | -- | -- | -$0.26 | -$0.31 | $0.05 |
| 05/14/2024 | Q1 | -- | -- | -$0.25 | -$0.38 | $0.13 |
| 03/29/2024 | Q4 | -- | -- | -$0.33 | -$0.37 | $0.04 |
| 11/14/2023 | Q3 | -- | -- | -$0.48 | -$0.39 | -$0.09 |
| 08/14/2023 | Q2 | -- | -- | -$0.52 | -$0.25 | -$0.27 |
| 05/15/2023 | Q1 | -- | -- | -$0.31 | -$0.29 | -$0.02 |
| 03/30/2023 | Q4 | -- | -- | -$0.58 | -$0.23 | -$0.35 |
| 11/14/2022 | Q3 | -- | -- | -$0.18 | -$0.26 | $0.08 |
| 08/15/2022 | Q2 | -- | -- | -$0.29 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.40 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.22 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$0.12 | -- | -- |
| 08/16/2021 | Q2 | -- | -- | -$0.12 | -- | -- |
| 05/17/2021 | Q1 | -- | -- | -$0.10 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.42 | -- | -- |
| 01/14/2021 | Q4 | -- | -- | -$0.04 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.24 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.31 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.27 | -- | -- |
Reviva Pharmaceuticals Holdings Earnings Questions
-
How Much did Reviva Pharmaceuticals Holdings Generate in Revenue Last Quarter?
Reviva Pharmaceuticals Holdings reported -- worth of top line sales in its most recent quarter.
-
Did Reviva Pharmaceuticals Holdings Beat Earnings Last Quarter?
Reviva Pharmaceuticals Holdings announced earnings per share of -$0.25 which represents a miss of analyst forecast a -$0.25 per share.
-
Is Reviva Pharmaceuticals Holdings Profitable?
Reviva Pharmaceuticals Holdings reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Reviva Pharmaceuticals Holdings EPS Next Year?
Reviva Pharmaceuticals Holdings's earnings are forecast to decrease from -$1.65 per share to -$0.99 per share next year representing a decrease of -39.7%.
-
When is Reviva Pharmaceuticals Holdings's Earnings Date?
Reviva Pharmaceuticals Holdings's next earnings date is April 15, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 24
Regencell Bioscience Holdings [RGC] is down 21.49% over the past day.
Buy
54
TNXP alert for Mar 24
Tonix Pharmaceuticals Holding [TNXP] is up 38.12% over the past day.
Sell
36
VMI alert for Mar 24
Valmont Industries [VMI] is up 5.64% over the past day.
